Annual EBITDA
$73.51 M
+$3.08 M+4.38%
December 31, 2024
Summary
- As of February 7, 2025, CLB annual EBITDA is $73.51 million, with the most recent change of +$3.08 million (+4.38%) on December 31, 2024.
- During the last 3 years, CLB annual EBITDA has risen by +$9.73 million (+15.26%).
- CLB annual EBITDA is now -80.30% below its all-time high of $373.23 million, reached on December 31, 2014.
Performance
CLB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$17.84 M
-$5.64 M-24.03%
December 31, 2024
Summary
- As of February 7, 2025, CLB quarterly EBITDA is $17.84 million, with the most recent change of -$5.64 million (-24.03%) on December 31, 2024.
- Over the past year, CLB quarterly EBITDA has dropped by -$617.00 thousand (-3.34%).
- CLB quarterly EBITDA is now -81.68% below its all-time high of $97.35 million, reached on December 31, 2014.
Performance
CLB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$73.51 M
-$617.00 K-0.83%
December 31, 2024
Summary
- As of February 7, 2025, CLB TTM EBITDA is $73.51 million, with the most recent change of -$617.00 thousand (-0.83%) on December 31, 2024.
- Over the past year, CLB TTM EBITDA has increased by +$3.08 million (+4.38%).
- CLB TTM EBITDA is now -80.30% below its all-time high of $373.23 million, reached on December 31, 2014.
Performance
CLB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLB EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.4% | -3.3% | +4.4% |
3 y3 years | +15.3% | -3.3% | +4.4% |
5 y5 years | -38.4% | -3.3% | +4.4% |
CLB EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +25.3% | -24.0% | +328.2% | -0.8% | +47.3% |
5 y | 5-year | -38.4% | +231.4% | -36.8% | +117.2% | -38.4% | +227.6% |
alltime | all time | -80.3% | +231.4% | -81.7% | +117.2% | -80.3% | +227.6% |
Core Laboratories NV EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $73.51 M(+4.4%) | $17.84 M(-24.0%) | $73.51 M(-0.8%) |
Sep 2024 | - | $23.48 M(+18.7%) | $74.13 M(+7.0%) |
Jun 2024 | - | $19.78 M(+59.3%) | $69.25 M(-4.2%) |
Mar 2024 | - | $12.41 M(-32.7%) | $72.31 M(+2.7%) |
Dec 2023 | $70.42 M(+20.0%) | $18.45 M(-0.8%) | $70.42 M(-1.7%) |
Sep 2023 | - | $18.60 M(-18.6%) | $71.66 M(-0.3%) |
Jun 2023 | - | $22.84 M(+117.0%) | $71.88 M(+10.5%) |
Mar 2023 | - | $10.53 M(-46.5%) | $65.04 M(+10.8%) |
Dec 2022 | $58.69 M(-8.0%) | $19.69 M(+4.7%) | $58.69 M(+1.9%) |
Sep 2022 | - | $18.82 M(+17.5%) | $57.59 M(+15.4%) |
Jun 2022 | - | $16.01 M(+284.3%) | $49.91 M(-3.0%) |
Mar 2022 | - | $4.17 M(-77.6%) | $51.45 M(-19.3%) |
Dec 2021 | $63.78 M(-214.0%) | $18.60 M(+67.0%) | $63.78 M(-13.1%) |
Sep 2021 | - | $11.14 M(-36.6%) | $73.42 M(-6.8%) |
Jun 2021 | - | $17.55 M(+6.4%) | $78.78 M(+22.9%) |
Mar 2021 | - | $16.49 M(-41.6%) | $64.09 M(-214.6%) |
Dec 2020 | -$55.94 M(-146.9%) | $28.24 M(+71.2%) | -$55.94 M(-2.9%) |
Sep 2020 | - | $16.50 M(+477.2%) | -$57.59 M(+54.9%) |
Jun 2020 | - | $2.86 M(-102.8%) | -$37.18 M(+495.5%) |
Mar 2020 | - | -$103.53 M(-489.4%) | -$6.24 M(-105.2%) |
Dec 2019 | $119.29 M(-15.8%) | $26.59 M(-27.9%) | $119.29 M(+2.5%) |
Sep 2019 | - | $36.90 M(+9.2%) | $116.40 M(-3.0%) |
Jun 2019 | - | $33.79 M(+53.6%) | $120.05 M(-4.4%) |
Mar 2019 | - | $22.00 M(-7.2%) | $125.58 M(-11.4%) |
Dec 2018 | $141.71 M(+5.4%) | $23.70 M(-41.6%) | $141.71 M(-9.4%) |
Sep 2018 | - | $40.56 M(+3.2%) | $156.45 M(+5.3%) |
Jun 2018 | - | $39.32 M(+3.1%) | $148.56 M(+4.0%) |
Mar 2018 | - | $38.13 M(-0.8%) | $142.78 M(+6.2%) |
Dec 2017 | $134.49 M(+17.6%) | $38.44 M(+17.7%) | $134.49 M(+7.3%) |
Sep 2017 | - | $32.66 M(-2.6%) | $125.39 M(+3.7%) |
Jun 2017 | - | $33.54 M(+12.4%) | $120.94 M(+5.7%) |
Mar 2017 | - | $29.84 M(+1.7%) | $114.38 M(+0.0%) |
Dec 2016 | $114.32 M(-39.4%) | $29.35 M(+4.0%) | $114.32 M(-1.2%) |
Sep 2016 | - | $28.21 M(+4.6%) | $115.67 M(-18.1%) |
Jun 2016 | - | $26.98 M(-9.4%) | $141.19 M(-16.5%) |
Mar 2016 | - | $29.79 M(-3.0%) | $169.03 M(-10.3%) |
Dec 2015 | $188.53 M(-49.5%) | $30.69 M(-42.9%) | $188.53 M(-26.1%) |
Sep 2015 | - | $53.73 M(-2.0%) | $255.18 M(-14.2%) |
Jun 2015 | - | $54.82 M(+11.2%) | $297.42 M(-10.7%) |
Mar 2015 | - | $49.28 M(-49.4%) | $333.05 M(-10.8%) |
Dec 2014 | $373.23 M(+4.0%) | $97.35 M(+1.4%) | $373.23 M(+0.7%) |
Sep 2014 | - | $95.97 M(+6.1%) | $370.52 M(+1.3%) |
Jun 2014 | - | $90.45 M(+1.1%) | $365.91 M(+0.7%) |
Mar 2014 | - | $89.46 M(-5.5%) | $363.29 M(+1.2%) |
Dec 2013 | $358.89 M(+12.1%) | $94.65 M(+3.6%) | $358.89 M(+3.8%) |
Sep 2013 | - | $91.35 M(+4.0%) | $345.61 M(+2.8%) |
Jun 2013 | - | $87.83 M(+3.3%) | $336.10 M(+3.3%) |
Mar 2013 | - | $85.06 M(+4.5%) | $325.47 M(+1.6%) |
Dec 2012 | $320.20 M(+17.3%) | $81.37 M(-0.6%) | $320.20 M(+0.8%) |
Sep 2012 | - | $81.84 M(+6.0%) | $317.51 M(+4.1%) |
Jun 2012 | - | $77.20 M(-3.2%) | $304.94 M(+4.7%) |
Mar 2012 | - | $79.79 M(+1.4%) | $291.13 M(+6.6%) |
Dec 2011 | $273.05 M(+10.1%) | $78.67 M(+13.6%) | $273.05 M(+4.8%) |
Sep 2011 | - | $69.27 M(+9.3%) | $260.46 M(+1.5%) |
Jun 2011 | - | $63.40 M(+2.8%) | $256.55 M(+1.5%) |
Mar 2011 | - | $61.70 M(-6.6%) | $252.63 M(+1.8%) |
Dec 2010 | $248.10 M(+17.7%) | $66.09 M(+1.1%) | $248.10 M(+6.7%) |
Sep 2010 | - | $65.36 M(+9.9%) | $232.61 M(+7.0%) |
Jun 2010 | - | $59.49 M(+4.1%) | $217.48 M(+0.9%) |
Mar 2010 | - | $57.17 M(+13.0%) | $215.58 M(+2.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | $210.74 M(-10.6%) | $50.60 M(+0.8%) | $210.80 M(-6.5%) |
Sep 2009 | - | $50.22 M(-12.8%) | $225.45 M(-4.4%) |
Jun 2009 | - | $57.59 M(+9.9%) | $235.86 M(-1.2%) |
Mar 2009 | - | $52.38 M(-19.7%) | $238.64 M(+1.2%) |
Dec 2008 | $235.68 M(+15.9%) | $65.25 M(+7.6%) | $235.86 M(+0.4%) |
Sep 2008 | - | $60.63 M(+0.4%) | $234.85 M(+4.1%) |
Jun 2008 | - | $60.37 M(+21.7%) | $225.57 M(+6.2%) |
Mar 2008 | - | $49.61 M(-22.8%) | $212.37 M(+3.8%) |
Dec 2007 | $203.32 M(+43.9%) | $64.24 M(+25.1%) | $204.68 M(+12.4%) |
Sep 2007 | - | $51.35 M(+8.9%) | $182.08 M(+7.7%) |
Jun 2007 | - | $47.16 M(+12.5%) | $169.06 M(+7.6%) |
Mar 2007 | - | $41.92 M(+0.7%) | $157.17 M(+9.3%) |
Dec 2006 | $141.25 M(+81.1%) | $41.64 M(+8.6%) | $143.79 M(+16.7%) |
Sep 2006 | - | $38.34 M(+8.7%) | $123.25 M(+19.5%) |
Jun 2006 | - | $35.27 M(+23.6%) | $103.17 M(+16.3%) |
Mar 2006 | - | $28.54 M(+35.3%) | $88.73 M(+13.8%) |
Dec 2005 | $77.99 M(+22.0%) | $21.09 M(+15.5%) | $77.99 M(+2.1%) |
Sep 2005 | - | $18.26 M(-12.3%) | $76.36 M(+1.2%) |
Jun 2005 | - | $20.83 M(+17.0%) | $75.45 M(+11.5%) |
Mar 2005 | - | $17.81 M(-8.5%) | $67.67 M(+5.6%) |
Dec 2004 | $63.91 M(+13.8%) | $19.46 M(+12.1%) | $64.11 M(+1.7%) |
Sep 2004 | - | $17.36 M(+33.0%) | $63.05 M(+0.5%) |
Jun 2004 | - | $13.05 M(-8.4%) | $62.72 M(+0.6%) |
Mar 2004 | - | $14.24 M(-22.6%) | $62.32 M(+10.7%) |
Dec 2003 | $56.16 M(+38.6%) | $18.40 M(+8.0%) | $56.31 M(+14.2%) |
Sep 2003 | - | $17.03 M(+34.6%) | $49.30 M(+8.7%) |
Jun 2003 | - | $12.65 M(+53.7%) | $45.34 M(+1.3%) |
Mar 2003 | - | $8.23 M(-27.7%) | $44.76 M(-6.7%) |
Dec 2002 | $40.52 M(-34.7%) | $11.39 M(-12.8%) | $47.99 M(+7.5%) |
Sep 2002 | - | $13.07 M(+8.2%) | $44.63 M(-14.1%) |
Jun 2002 | - | $12.07 M(+5.3%) | $51.95 M(-9.3%) |
Mar 2002 | - | $11.46 M(+42.7%) | $57.30 M(-7.8%) |
Dec 2001 | $62.09 M(+15.5%) | $8.03 M(-60.6%) | $62.13 M(-12.8%) |
Sep 2001 | - | $20.39 M(+17.1%) | $71.21 M(+8.7%) |
Jun 2001 | - | $17.42 M(+7.0%) | $65.48 M(+8.8%) |
Mar 2001 | - | $16.29 M(-4.8%) | $60.16 M(+11.5%) |
Dec 2000 | $53.75 M(+37.3%) | $17.11 M(+16.6%) | $53.95 M(+21.5%) |
Sep 2000 | - | $14.67 M(+21.2%) | $44.41 M(-1.6%) |
Jun 2000 | - | $12.10 M(+20.1%) | $45.11 M(+5.8%) |
Mar 2000 | - | $10.08 M(+33.3%) | $42.64 M(+9.4%) |
Dec 1999 | $39.16 M(-31.3%) | $7.56 M(-50.8%) | $38.99 M(-12.7%) |
Sep 1999 | - | $15.37 M(+59.6%) | $44.64 M(-9.4%) |
Jun 1999 | - | $9.63 M(+49.8%) | $49.27 M(-8.0%) |
Mar 1999 | - | $6.43 M(-51.3%) | $53.54 M(-6.4%) |
Dec 1998 | $57.01 M(+36.7%) | $13.21 M(-33.9%) | $57.21 M(-5.4%) |
Sep 1998 | - | $20.00 M(+43.9%) | $60.50 M(+16.1%) |
Jun 1998 | - | $13.90 M(+37.6%) | $52.10 M(+9.9%) |
Mar 1998 | - | $10.10 M(-38.8%) | $47.40 M(+13.1%) |
Dec 1997 | $41.70 M(+143.9%) | $16.50 M(+42.2%) | $41.90 M(+39.7%) |
Sep 1997 | - | $11.60 M(+26.1%) | $30.00 M(+29.3%) |
Jun 1997 | - | $9.20 M(+100.0%) | $23.20 M(+28.2%) |
Mar 1997 | - | $4.60 M(0.0%) | $18.10 M(+4.0%) |
Dec 1996 | $17.10 M(+29.5%) | $4.60 M(-4.2%) | $17.40 M(+6.7%) |
Sep 1996 | - | $4.80 M(+17.1%) | $16.30 M(+9.4%) |
Jun 1996 | - | $4.10 M(+5.1%) | $14.90 M(-49.3%) |
Mar 1996 | - | $3.90 M(+11.4%) | $29.40 M(-32.1%) |
Dec 1995 | $13.20 M | $3.50 M(+2.9%) | $43.30 M(+8.8%) |
Sep 1995 | - | $3.40 M(-81.7%) | $39.80 M(+9.3%) |
Jun 1995 | - | $18.60 M(+4.5%) | $36.40 M(+104.5%) |
Mar 1995 | - | $17.80 M | $17.80 M |
FAQ
- What is Core Laboratories NV annual EBITDA?
- What is the all time high annual EBITDA for Core Laboratories NV?
- What is Core Laboratories NV annual EBITDA year-on-year change?
- What is Core Laboratories NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for Core Laboratories NV?
- What is Core Laboratories NV quarterly EBITDA year-on-year change?
- What is Core Laboratories NV TTM EBITDA?
- What is the all time high TTM EBITDA for Core Laboratories NV?
- What is Core Laboratories NV TTM EBITDA year-on-year change?
What is Core Laboratories NV annual EBITDA?
The current annual EBITDA of CLB is $73.51 M
What is the all time high annual EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high annual EBITDA is $373.23 M
What is Core Laboratories NV annual EBITDA year-on-year change?
Over the past year, CLB annual EBITDA has changed by +$3.08 M (+4.38%)
What is Core Laboratories NV quarterly EBITDA?
The current quarterly EBITDA of CLB is $17.84 M
What is the all time high quarterly EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high quarterly EBITDA is $97.35 M
What is Core Laboratories NV quarterly EBITDA year-on-year change?
Over the past year, CLB quarterly EBITDA has changed by -$617.00 K (-3.34%)
What is Core Laboratories NV TTM EBITDA?
The current TTM EBITDA of CLB is $73.51 M
What is the all time high TTM EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high TTM EBITDA is $373.23 M
What is Core Laboratories NV TTM EBITDA year-on-year change?
Over the past year, CLB TTM EBITDA has changed by +$3.08 M (+4.38%)